HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Quon, A. Articles by Kaplan, M. J. Search for Related Content PubMed PubMed Citation Articles by Quon, A. Articles by Kaplan, M. J.

Clinical Role of ¹⁸F-FDG PET/CT in the Management of Squamous Cell Carcinoma of the Head and Neck and Thyroid Carcinoma

¹ Division of Nuclear Medicine, Department of Radiology, Stanford University Medical Center, Stanford, California; ² Division of Neuroradiology, Department of Radiology, Stanford University Medical Center, Stanford, California; ³ Department of Radiation Oncology, Stanford University Medical Center, Stanford, California; ⁴ Division of Oncology, Department of Internal Medicine, Stanford University Medical Center, Stanford, California; and ⁵ Department of Otolaryngology and Head and Neck Surgery, Stanford University Medical Center, Stanford, California

Correspondence: For correspondence contact: Andrew Quon, MD, Division of Nuclear Medicine, Department of Radiology, 300 Pasteur Dr., Stanford, CA 94305. E-mail: aquon{at}stanford.edu

¹⁸F-FDG PET/CT has rapidly become a widely used imaging modality for evaluating a variety of malignancies, including squamous cell carcinoma of the head and neck and thyroid cancer. Using both published data and the multidisciplinary experience at our institution, we provide a practical set of guidelines and algorithms for the use of ¹⁸F-FDG PET/CT in the evaluation and management of head and neck cancer and thyroid cancer.

Key Words: ¹⁸F-FDG • PET/CT • head and neck carcinoma • thyroid carcinoma

COPYRIGHT © 2006 by the Society of Nuclear Medicine, Inc.

This article has been cited by other articles:

				A. McKeon, M. Apiwattanakul, D. H. Lachance, V. A. Lennon, J. N. Mandrekar, B. F. Boeve, B. Mullan, B. Mokri, J. W. Britton, D. A. Drubach, et al. Positron Emission Tomography- Computed Tomography in Paraneoplastic Neurologic Disorders: Systematic Analysis and Review Arch Neurol, January 11, 2010; (2010) 2009.336. [Abstract] [Full Text] [PDF]

				H. Schoder, M. Fury, N. Lee, and D. Kraus PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma J. Nucl. Med., May 1, 2009; 50(Suppl_1): 74S - 88S. [Abstract] [Full Text] [PDF]

				C.-H. Baek, M. K. Chung, Y.-I. Son, J. Y. Choi, H.-J. Kim, Y. J. Yim, Y. H. Ko, J. Choi, J. K. Cho, and H.-S. Jeong Tumor Volume Assessment by 18F-FDG PET/CT in Patients with Oral Cavity Cancer with Dental Artifacts on CT or MR Images J. Nucl. Med., September 1, 2008; 49(9): 1422 - 1428. [Abstract] [Full Text] [PDF]

				J.M. Debnam, A.S. Garden, and L.E. Ginsberg Benign Ulceration as a Manifestation of Soft Tissue Radiation Necrosis: Imaging Findings AJNR Am. J. Neuroradiol., March 1, 2008; 29(3): 558 - 562. [Abstract] [Full Text] [PDF]

				J. Czernin and H. R. Schelbert Introduction J. Nucl. Med., January 1, 2007; 48(1_suppl): 2S - 3S. [Full Text] [PDF]